Pharmacists in West Saint Paul, MN Accepting Medicare
9 Pharmacists found. Showing 1 - 9
 Mai Hoang Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 1471 Robert St S, West Saint Paul, MN 55118 Phone: 651-552-6029 |
Dr. Justine Olson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1750 Robert St S, West Saint Paul, MN 55118 Phone: 651-455-6626 |
Mindy Nguyen Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1471 Robert St S, West Saint Paul, MN 55118 Phone: 651-552-6029 |
Dr. Heather Koser Baradan, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1750 Robert St S, West Saint Paul, MN 55118 Phone: 651-455-6626 Fax: 651-455-1903 |
 Dr. Justyn Patrick Mileski, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2001 Robert St S, West Saint Paul, MN 55118 Phone: 651-451-1113 Fax: 651-451-1909 |
Rihab Shoshan Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 50 Signal Hills Ctr, West Saint Paul, MN 55118 Phone: 651-457-3355 |
Nur I Odowa Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1133 Robert St S, West Saint Paul, MN 55118 Phone: 651-455-5590 |
Eric Graham Dorr, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 149 Thompson Ave East, Suite 150, West Saint Paul, MN 55118 Phone: 612-284-2130 |
Dr. Lauren Lee Ketchmark, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2001 Robert St S, West Saint Paul, MN 55118 Phone: 651-451-1113 |
News Archive
Nanotubes sniff out cancer agents in living cells
A multidisciplinary team at the Massachusetts Institute of Technology (MIT) has developed carbon nanotubes that can be used as sensors for cancer drugs and other DNA-damaging agents inside living cells. The sensors, made of carbon nanotubes wrapped in DNA, can detect chemotherapy drugs such as cisplatin as well as environmental toxins and free radicals that damage DNA.
NIAID awards $6.25M to Profectus to optimize portfolio of genetic adjuvants
Profectus BioSciences, Inc., a technology based vaccine company devoted to the treatment and prevention of chronic viral diseases, today announced that it has received $6.25M in National Institute of Allergy and Infectious Disease (NIAID) grants and contracts.
Dabigatran decreases risk of recurrent venous thromboembolism
New findings from two double-blind, randomized trials, RE-MEDY and RE-SONATE, show that dabigatran 150 mg twice daily reduces the risk of recurrent venous thromboembolism (VTE).
Studies offer new insight into diverticulosis
Diverticulosis, a condition that develops when pouches form in the wall of the colon, is increasing in frequency. It affects the majority of those reaching the age of 80 - a growing portion of the population - and imposes a substantial burden on health-care resources, but curiously there is a lack of data and unanswered questions around this condition.
› Verified 6 days ago
Pharmacists
Dentists
Counselors
Psychologists
Marriage Counselors
Clinical Social Workers
Occupational Therapists